ClinicalTrials.gg
CompletedNCT03360136Updated Feb 21, 2023

Open Clinical Trial of CBT-based Multiprofessional Rehabilitation for Exhaustion Disorder

An interventional study of Multi-professional CBT-rehabilitation in Exhaustion; Syndrome, Burnout, Professional and Burnout Syndrome, sponsored by Uppsala University. Completed at 2 sites in Sweden. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2023-02-21.

Primary conditionBurnout, ProfessionalRegistry: SyndromeReclassifiedWhy we changed it
Registry
Syndrome — the first condition term the registry derived for this study.
ClinicalTrials.gg
Burnout, Professional
Why
  1. Syndrome describes something many studies share rather than a condition a study is about.
  2. The study's listed conditions name Burnout, Professional.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Uppsala University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Not applicable
Ages
18 Years to 64 Years
Sex
All
01

Study summary

Stress-related mental disorders are today the leading cause of long-term sick leave in Sweden, and a large part of this increase is due to Clinical burnout, in Sweden called "Exhaustion disorder" (ED). Even though clinical guidelines recommend multi-professional rehabilitation (MPR) for ED, few studies have evaluated the effects of these treatment programs in clinical practice. This large-scale open clinical trial investigates whether MPR for ED seems to alleviate symptoms of ED and if it results in return-to-work.

Read the detailed description

This study is carried out at two specialized stress rehabilitation centers in Stockholm. All patients included in the clinics stress rehabilitation program are asked to participate in the study and are recruited consecutively from October 2017 throughout December 2018. An estimate of 400 patients will be included. The treatment program is a 24-week Multiprofessional standardized CBT-rehabilitation consisting of a nine-session CBT group treatment (stress management) followed by a seven-session group treatment in applied relaxation. Parallel to the group treatments patients receives nine sessions of individual CBT, three visits to an MD (for medication, follow-up, and sick-listing), two individual sessions to a physiotherapist and a three session-exercise group. Also, vocational measures are taken through rehabilitation meetings together with the patient's employer (if an employer exists). Primary treatment outcomes will be return-to-work (RTW) and symptoms of ED, anxiety, and depression. Secondary treatment outcomes will be quality of life, pathological worry, psychological flexibility, clinical perfectionism, insomnia, burnout, and symptoms. Predictors of symptom development and RTW will be explored. Also, comorbidity of chronic pain, negative effects of psychotherapy and treatment credibility will be investigated.

02

Conditions studied

  • Exhaustion; Syndrome
  • Burnout, Professional
  • Burnout Syndrome
  • Adjustment Disorders

Browse trials for

Keywords

  • Exhaustion Disorder
  • Burnout
  • Clinical Burnout
03

In context

Burnout, Professional Reclassified

216 studies on the registry are indexed under Burnout, Professional; 33 are open to participants now.

This study's enrollment of 1,000 is above the median of 80 across 161 interventional studies indexed under Burnout, Professional.

Browse Burnout, Professional studies →

Lead sponsor

Uppsala University is the lead sponsor of 390 studies on the registry; 86 are open to participants now.

Compared within Burnout, Professional, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Syndrome. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Confirmed exhaustion disorder according to criteria established by the Swedish National Board of Health and Welfare
  • 18 - 64 years of age
  • Considered suitable for multimodal rehabilitation in group
  • Self-rating of > 4,5 på SMBQ

Exclusion criteria

Exclusion Criteria:

  • Abuse of alcohol or drugs
  • Moderate-high suicidal risk
  • Severe psychiatric illness (severe depression, bipolar, schizophrenia etc.)
  • Untreated PTSD
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,000 participants (actual)

Study arms

  • Other
    Multi-professional CBT-rehabilitation

    24 weeks CBT-based multi-professional rehabilitation.

    Behavioral: Multi-professional CBT-rehabilitation

Interventions

  • BehavioralMulti-professional CBT-rehabilitation

    See "Detailed description"

06

What researchers measure

Primary outcomes

  1. Change from baseline in exhaustion symptoms

    Self-reported change in Karolinska Exhaustion Disorder Scale, 9 items

    Time frame: Week 12 and 24

  2. Change from baseline to follow-up in exhaustion symptoms

    Self-reported change in Karolinska Exhaustion Disorder Scale, 9 items

    Time frame: Week 12, 24 and 76

  3. Change from baseline in depression

    Self-reported change in Hospital Anxiety Depressin Scale (HADS), 14 items

    Time frame: Week 12 and 24

  4. Change from baseline to follow-up in depression

    Self-reported change in Hospital Anxiety Depressin Scale (HADS), 14 items

    Time frame: Week 12, 24 and 76

  5. Change from baseline in anxiety

    Self-reported change in Hospital Anxiety Depressin Scale (HADS), 14 items

    Time frame: Week 12 and 24

  6. Change from baseline to follow-up in anxiety

    Self-reported change in Hospital Anxiety Depressin Scale (HADS), 14 items

    Time frame: Week 12, 24 and 76

  7. Change from baseline in employment rate

    Sick-leave data collected from the Swedish Social Insurance Agency

    Time frame: Week 24

  8. Change from baseline to follow-up in employment rate

    Sick-leave data collected from the Swedish Social Insurance Agency

    Time frame: Week 24 and 76

Secondary outcomes

  1. Change from baseline in Quality of life

    Self-reported change in EQ5D, 5 items

    Time frame: Week 24

  2. Change from baseline to follow-up in Quality of life

    Self-reported change in EQ5D, 5 items

    Time frame: Week 24 and 76

  3. Change from baseline in insomnia symptoms

    Self-reported change in Insomnia Severity Index (ISI), 7 items

    Time frame: Week 12 and 24

  4. Change from baseline to follow-up in insomnia symptoms

    Self-reported change in Insomnia Severity Index (ISI), 7 items

    Time frame: Week 12, 24 and 76

  5. Change from baseline in Clinical Perfectionism

    Self-reported change in Clinical Perfectionism Questionnaire (CPQ), 12 items

    Time frame: Week 12 and 24

  6. Change from baseline to follow-up in Clinical Perfectionism

    Self-reported change in Clinical Perfectionism Questionnaire (CPQ), 12 items

    Time frame: Week 12, 24 and 76

  7. Change from baseline in Psychological Flexibility

    Self-reported change in the Swedish Acceptance and Action Questionnaire (SAAQ), 6 items

    Time frame: Week 12 and 24

  8. Change from baseline to follow-up in Psychological Flexibility

    Self-reported change in the Swedish Acceptance and Action Questionnaire (SAAQ), 6 items

    Time frame: Week 12, 24 and 76

  9. Change from baseline in pathological worry

    Self reported change in Penn State Worry Questionnaire ultra-brief (PSWQ-brief), 3 items

    Time frame: Week 12 and 24

  10. Change from baseline to follow-up in pathological worry

    Self reported change in Penn State Worry Questionnaire ultra-brief (PSWQ-brief), 3 items

    Time frame: Week 12, 24 and 76

  11. Change from baseline in perceived work ability

    Self-rated work ability, 1 single item from Work Ability index (WAI)

    Time frame: Week 12 and 24

  12. Change from baseline to follow up in perceived work ability

    Self-rated work ability, 1 single item from Work Ability index (WAI)

    Time frame: Week 12, 24 and 76

  13. Change from baseline in burnout

    Self-rated burnout in Shirom Melamed Burnout Questionnaire (SMBQ), 22 items

    Time frame: Week 12 and 24

  14. Change from baseline to follow-up in burnout

    Self-rated burnout in Shirom Melamed Burnout Questionnaire (SMBQ), 22 items

    Time frame: Week 12, 24 and 76

Other outcomes

  1. Negative Effects of psychotherapy

    Self-Reported negative effects in Negative Effects Questionnaire, 32 items

    Time frame: at 24 week only

  2. Treatment credibility rating

    Self-reported treatment credibility, treatment Credibility Scale (TCS), 5 items

    Time frame: Baseline and at 12 weeks

07

Study locations

2 sites
  • PBM Sweden AB Globen
    Stockholm, Södermanland 12177, Sweden
  • PBM Sweden City
    Stockholm, Uppland 114 47, Sweden
08

References and documents

Publications

  • van de Leur JC, Buhrman M, Ahs F, Rozental A, Jansen GB. Standardized multimodal intervention for stress-induced exhaustion disorder: an open trial in a clinical setting. BMC Psychiatry. 2020 Nov 5;20(1):526. doi: 10.1186/s12888-020-02907-3. PubMed 33153461 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2017 to primary completion in Dec 2020, 38 months.

Of 128 non-industry interventional studies with no phase under Burnout, Professional, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 22. This study's 38 months is above that.

Counting every sponsor, half of 132 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2017
First posted
Dec 2, 2017
StartActual
Oct 1, 2017
Primary completionActual
Dec 29, 2020
CompletionActual
Dec 29, 2020
Last update
Feb 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03360136
Lead sponsor
Uppsala University
Collaborators
PBM Sweden AB
Responsible party
Sponsor
First posted
Dec 2, 2017
Start date
Oct 1, 2017
Primary completion
Dec 29, 2020
Completion
Dec 29, 2020
Last update
Feb 21, 2023

Study contacts

Gunilla Brodda Jansen, Assoc. Proff.
study chair · Karolinska University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion